Frequently Asked Questions
The market is segmented based on , By Type (Molecular Engineering, Genetic Engineering and Genome Editing and Others), Trait (Yield Improvement, Disease Resistance, Herbicide Tolerance and Insect Resistance and Abiotic Stress Tolerance), Objectives (DNA Extraction and Purification, DNA/RNA Sequencing, Genotyping, Gene Expression Profiling, Marker-Assisted Selection, GMO-Trait Purity Testing, Hybrid Purity Testing, Targeted Resequencing, DNA Parentage Testing, QTL Mapping and Genetic Disease), Application (Cereals and Grains, Oilseeds and Pulses, Fruits and Vegetables, Sugar Crops, Ornamentals and Alfalfa - (Industry Trends and Forecast to 2023 to 2030.
.
The Global Genetic Engineering Plant Genomics Market size was valued at USD 31.56 USD Billion in 2021.
The Global Genetic Engineering Plant Genomics Market is projected to grow at a CAGR of 8.7% during the forecast period of 2022 to 2029.
The major players operating in the market include Eurofins Scientific, Illumina , NRGene, Neogen Corporation, Agilent, LC Sciences LLC, Traitgenetics GmbH, Keygene, Novogene Co. Ltd, GeneWiz, BGI, Genotypic Technology, ADAMA, Bayer AG, UPL, Corteva, Zhejiang Xinan Chemical Industrial Group Co. Ltd, Nufarm, DuPont, Syngenta AG, VILMORIN & CIE, SUNTORY HOLDINGS LIMITED.
The market report covers data from the U.S., Canada, Mexico, Brazil, Argentina, Rest of South America, Germany, France, Italy, U.K., Belgium, Spain, Russia, Turkey, Netherlands, Switzerland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, U.A.E., Saudi Arabia, Egypt, South Africa, Israel, and Rest of Middle East and Africa.
